67 related articles for article (PubMed ID: 3228023)
1. [Serum secretory IgA level in patients with Behçet's disease].
Nio T; Sunakawa M; Ohshio G; Arai I; Okinami S
Nippon Ganka Gakkai Zasshi; 1988 Nov; 92(11):1740-3. PubMed ID: 3228023
[No Abstract] [Full Text] [Related]
2. Serum secretory IgA levels in patients with Behçet disease.
Sunakawa M; Ohshio G
Metab Pediatr Syst Ophthalmol (1985); 1989; 12(4):110-2. PubMed ID: 2628704
[TBL] [Abstract][Full Text] [Related]
3. Secretory component deficiency in Behçet's disease.
Hamza M; Makni S
Clin Rheumatol; 1995 Mar; 14(2):227-8. PubMed ID: 7789068
[No Abstract] [Full Text] [Related]
4. Serum levels of Th2 cytokines IL-4 and IL-10 in Behçet's disease.
Mantaş C; Direskeneli H; Ekşioglu-Demiralp E; Akoglu T
J Rheumatol; 1999 Feb; 26(2):510-2. PubMed ID: 9972999
[No Abstract] [Full Text] [Related]
5. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
[TBL] [Abstract][Full Text] [Related]
6. Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease.
Abdou NI; Schumacher HR; Colman RW; Sagawa A; Hebert J; Pascual E; Carroll ET; Miller M; South MA; Abdou NL
J Lab Clin Med; 1978 Mar; 91(3):409-22. PubMed ID: 627747
[TBL] [Abstract][Full Text] [Related]
7. [The antibody titer to streptococcal and staphylococcal L-form in Behçet's disease].
Ogawa T; Namba K; Nishiyama Y; Sawada K
Nippon Ganka Gakkai Zasshi; 1990 Apr; 94(4):408-12. PubMed ID: 2396591
[TBL] [Abstract][Full Text] [Related]
8. Serum neopterin levels in Behçet's syndrome.
Keser G; Oksel F; Aksu K; Kabasakal Y; Gümüşdiş G; Doganavş argil E; Sin A
Clin Rheumatol; 2000; 19(4):328-9. PubMed ID: 10941821
[No Abstract] [Full Text] [Related]
9. Tetanus antitoxin seroprevalence in patients with Behçet's disease.
Ayaslioglu E; Erkek E; Kiliç D; Kaygusuz S; Karaca F; Düzgün N
Scand J Infect Dis; 2003; 35(5):299-301. PubMed ID: 12875513
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
[TBL] [Abstract][Full Text] [Related]
11. [A study of antiendothelial cell antibodies in Behcet's disease].
Zheng WJ; Zhao Y; Tang FL; Dong Y
Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):910-3. PubMed ID: 16409728
[TBL] [Abstract][Full Text] [Related]
12. [The relation between Behçet's disease and interleukin-1 beta production].
Katayama T; Tachinami K; Ishiguro M; Kubota Y
Nippon Ganka Gakkai Zasshi; 1994 Feb; 98(2):197-201. PubMed ID: 8109465
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
[TBL] [Abstract][Full Text] [Related]
14. Increased solubilization of immune complexes by the sera from patients with Behcet's disease.
Tanaka K; Kajiyama K; Kameda S; Nishigouri S; Yamada I; Sawae Y
Tohoku J Exp Med; 1983 Aug; 140(4):363-8. PubMed ID: 6636135
[TBL] [Abstract][Full Text] [Related]
15. Levels of serum transforming growth factor-beta1 do not increase in Behçet's disease, in contrast to rheumatoid arthritis.
Eksioglu-Demiralp E; Direskeneli H; Akoglu T
J Rheumatol; 1999 Apr; 26(4):1010-1. PubMed ID: 10229441
[No Abstract] [Full Text] [Related]
16. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of T-cell subsets in Behçet's syndrome.
Lim SD; Haw CR; Kim NI; Fusaro RM
Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
[TBL] [Abstract][Full Text] [Related]
18. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
Kagawa H; Okubo S
Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
[TBL] [Abstract][Full Text] [Related]
19. Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
Houman H; Ben Ghorbel I; Lamloum M; Feki M; Khanfir M; Mebazaa A; Miled M
Ann Med Interne (Paris); 2001 Apr; 152(3):209-11. PubMed ID: 11431583
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
